World Health Organization or WHO experts on vaccine safety will be meeting on Tuesday for discussing about the Covid-19 vaccine of Oxford-AstraZeneca, as the number of the countries that are temporarily halting the rollout over various blood clotting issues continues to grow.
Some More European Countries Join The Decision To Temporarily Banning Oxford-AstraZeneca Over Blood Clotting Issues
On Tuesday, Luxembourg, Cyprus, Sweden, and Latvia have become some of the latest European nations for suspending the use of this vaccine, even the international medical agencies advise that the vaccine’s benefits for getting doses in the arms outweigh any major risks.
On Monday, WHO had appealed to all countries to continue the vaccination campaigns, ting there is no evidence that the vaccine can cause any blood clotting concerns.
Christian Lindmeier, a WHO spokesman said that till now there is no concrete evidence which states that these incidents are caused by the vaccination and it is essential for the vaccine programs to continue so that the nations can save more lives and eradicate these diseases due to the Covid-19 virus.
WHO has already said that it is assessing the current reports of various thromboembolic events, but it is already biased in its decision when it said that these were “unlikely” to change its decision to hald this vaccine.
The EMA or European Medical Authority which is Europe’s medicines regulator has allowed the use of this vaccine shot to the 27-nation bloc. They have also convened that a special meeting will be hosted on Thursday that will be reviewing the information which it has gathered. The main objective is to see whether AstraZeneca vaccine is influencing blood clotting in the vaccinated people. EMA has asked the countries to continue vaccination campaigns while they are investigating these cases.
But most of Europe has decided to go against this advice in recent days, they have temporarily suspended AstraZeneca vaccine shots even though the continent is undergoing a third wave of this Covid-19 pandemic, which is spurred by different variants of the Covid-19, and also has faced criticism over the slow vaccination campaigning.
Denmark is the first country to pause the use of the AstraZeneca vaccine on Thursday as a “precautionary measure” taken while some Danish health officials are investigating some of the big side effects after a person has developed a kind of blood clot from the vaccination and died unfortunately. Norway, Bulgaria and Iceland had quickly followed its suit.
A Danish woman has died from the vaccination after she was detected with a lower number of the platelets, numerous blood clots in the large and small vessels, and internal bleeding, as per the Danish Medicines Agency.
The picture of clinics is unusual and is being thoroughly investigated by the agency of European Medicines as reported by the agency on Monday.
In Norway another death was reported on Monday, coupled with a handful of cases although non-fatal but with similar “unusual” adverse reactions, the Norwegian Medicines Agency said. The agency said that it has already received more than 1,000 reports of side effects lately which it said it is reviewing currently.
Meanwhile AstraZeneca has doubled down on its vaccine’s safety. On Sunday, the pharmaceutical giant remarked that out of the 17 million people that were vaccinated in the United Kingdom and European Union so far, incidents of blood clotting are much lower than expected to happen naturally in a big population.”
Still, France, Spain, Italy, Germany, Portugal, the Netherlands, Ireland and Indonesia have joined countries suspending AstraZeneca vaccinations.
Besides most countries that issued a suspension of AstraZeneca vaccine have admitted that there is no clear evidence yet that the blood clots have been caused by AstraZeneca shots.